Nanalysis Scientific (TSE:NSCI) has released an update.
Nanalysis Scientific Corp. reported a record first-quarter revenue in 2024, with a 139% increase to $11.2 million compared to the same period last year, largely due to a surge in service revenue and product sales, including Benchtop NMR units. The company also experienced a significant improvement in gross margins and a reduction in net loss, indicating progress towards profitability. These positive results are underpinned by ongoing cost-reduction initiatives and strong sales pipeline momentum.
For further insights into TSE:NSCI stock, check out TipRanks’ Stock Analysis page.
